Xin Lin

china pharmaceutical university

H指数:15

被引数:2,356

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The cGAS-STING pathway in cancer: friend or foe

癌症中的cGAS-STING通路：朋友还是敌人？

Cell Death & Disease

IF9.6

2026-03-250

OAAI

Engineered Biomimetic Nanoparticles With Targeted Delivery of Chlorothiazide for the Treatment of Inflammatory Bowel Disease

工程化仿生纳米粒子靶向递送氯噻嗪治疗炎症性肠病

Angewandte Chemie International Edition

IF16.9

2026-03-050

PRE

Bidirectional microbial regulation by tyrosine metabolism enhances palmatine-mediated colitis protection

酪氨酸代谢的双向微生物调控增强了巴马汀介导的结肠炎保护作用

Gut Microbes

IF11

2025-12-090

OAAI

Treatment-agnostic joint modeling of longitudinal circulating tumor dna predicts survival across first-line regimens in metastatic non-squamous NSCLC

治疗不敏感的纵向循环肿瘤DNA联合建模预测了转移性非鳞状NSCLC中一线方案的整体生存情况

European Journal of Pharmaceutical Sciences

IF4.7

2025-09-150

OAAI

Early-Life Red Light Exposure Extends Lifespan in C. elegans through ROS-AMPK-Driven Mitochondrial Reprogramming

早期低龄期红光暴露通过ROS-AMPK驱动的线粒体重编程延长C. elegans寿命

AGING AND DISEASE

IF6.9

2025-09-010

OAAI

Regulatory mechanisms of PD-1/PD-L1 in cancers

PD-1/PD-L1在癌症中的调控机制

MOLECULAR CANCER

IF33.9

2024-05-1824

OAAI

Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-12-0115

PRE

Targeting of the FOXM1 Oncoprotein by E3 Ligase-Assisted Degradation

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2021-11-2330

PREAI

Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo

发现具有口服活性的VHL募集PROTAC，可在体内实现强大的HMGCR降解和有效的降血脂活性

ACTA PHARMACEUTICA SINICA B

IF14.6

2021-05-0158

OAAI

Structure-guided modification of isoxazole-type FXR agonists: Identification of a potent and orally bioavailable FXR modulator

异恶唑型FXR激动剂的结构指导修饰: 鉴定有效且口服生物可利用的FXR调节剂

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2021-01-017

PREAI

Discovery of novel steroidal-chalcone hybrids with potent and selective activity against triple-negative breast cancer

发现对三阴性乳腺癌具有强效和选择性活性的新型甾体-查尔酮杂种

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2020-12-0115

PREAI

Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-11-0168

PREAI

Kinetically Manipulating the Nucleus Attachment to Create Atypical Defective Rh-Pt Alloyed Nanostructures as Active Electrocatalysts

CHEMISTRY-AN ASIAN JOURNAL

IF3.3

2020-09-214

PREAI

Progress in PD-1/PD-L1 pathway inhibitors: From biomacromolecules to small molecules

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2020-01-01118

PREAI

Synthesis and biological evaluation of 3-aryl-quinolin derivatives as anti-breast cancer agents targeting ERα and VEGFR-2

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2019-01-0128

PREAI

Near-infrared MnCuInS/ZnS@BSA and urchin-like Au nanoparticle as a novel donor-acceptor pair for enhanced FRET biosensing

ANALYTICA CHIMICA ACTA

IF6

2018-12-0124

PREAI

TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression

ONCOGENE

IF7.3

2016-12-1937

PREAI

Tumor Vasculature Targeted Photodynamic Therapy for Enhanced Delivery of Nanoparticles

肿瘤血管靶向光动力疗法用于增强纳米颗粒的递送

ACS NANO

IF16

2014-05-12223

OAAI

Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against Cancer

ACS NANO

IF16

2013-07-11254

RGD-Modified Apoferritin Nanoparticles for Efficient Drug Delivery to Tumors

ACS NANO

IF16

2013-06-04343

Xin Lin

个人简介

教育背景

工作经历

荣誉奖项

研究方向